All articles

The Best Diabetes Apps in 2026: An Honest Comparison

PeterApril 18, 20268 min readFounder, Type 1 Diabetic since 1991
The Best Diabetes Apps in 2026: An Honest Comparison

I've been a Type 1 diabetic since 1991. I've used paper logbooks, early glucose meters, every major CGM system, and pretty much every diabetes app that exists. MySugr. SugarMate. The Dexcom app. The Libre app. Glooko. I've paid for premium tiers. I've exported data. I've sat in endocrinologist offices with printouts from all of them.

None of them gave me what I actually needed. They all do one thing well: show me what already happened. None of them help me prevent what's about to happen. That's the gap Open-D was built to fill. But this isn't a sales pitch. This is an honest breakdown of what each app does well, where they fall short, and why the category is still broken in 2026.

What I Evaluate In a Diabetes App

  • CGM integration quality β€” not just 'does it sync,' but how reliably and how fast
  • Pattern recognition β€” does it surface insights I wouldn't see myself?
  • Actionability β€” does it tell me what to DO, or just what happened?
  • Privacy β€” where does my health data live, and who else can access it?
  • Coaching β€” is there any guidance beyond generic thresholds?

MySugr: The Best Logger, Still Just a Logger

MySugr is genuinely well-designed. The logging flow is fast. The charts are clean. The estimated HbA1c feature is useful. If your goal is to track everything and generate reports for your doctor, it's probably the best option.

But that's all it does. It doesn't learn your patterns. It doesn't warn you before a low. It doesn't know that yesterday was leg day and today you're insulin sensitive. It's a beautiful, sophisticated logbook. Still a logbook.

Dexcom & Libre Apps: Display Tools, Not Agents

The Dexcom G7 app and Freestyle Libre 3 app are fine for what they are: receivers for your CGM data. They show current glucose, trends, and basic alerts. The Dexcom app has improved its sharing features for caregivers. The Libre app added some basic pattern summaries.

But neither app analyzes your data in any meaningful way. The 'insights' they surface are usually generic: 'Your average glucose was higher this week.' No context about why. No connection to your meals, workouts, or sleep. No memory of what worked last time you were in a similar situation.

SugarMate: Beautiful, Passive

SugarMate has gorgeous visualizations. The timeline view is genuinely useful for spotting patterns across a day. But like the others, it's reactive. It shows you beautiful charts of problems you've already had. It doesn't help you prevent the next one.

Gluroo: Free and Feature-Rich, But Built for Everyone

Gluroo is genuinely impressive: completely free, food photo AI logging, family sharing via 'GluCrew,' support for nearly every CGM and pump on the market, smartwatch apps, and a web dashboard for clinicians. It has 43,000 users and founders with serious tech backgrounds.

But it's built for everyone with diabetes β€” which means it's optimized for no one in particular. There are no sport-specific features. No workout correlation. No pharmacokinetic prediction. If you're a T1D athlete who needs to know what your glucose will do during a squat session versus a long run, Gluroo can't tell you. It's the best-designed free option I've seen. It's just not built for what I needed.

January AI: Impressive Tech, Wrong Problem

January AI won TIME's Best Invention of 2025, and the technology is genuinely impressive: it predicts glucose impact from food photos without even needing a CGM. That's a real achievement. Their food database has 54 million items and they launched enterprise APIs in 2026.

But January AI doesn't track insulin. It doesn't do workout correlation. It's a wellness and metabolic health tool aimed at people who want to understand food's glucose impact β€” without the complexity of insulin management. If you have T1D on MDI or a pump, January AI answers a question you already know the answer to and ignores the harder ones.

January AI tells you how food affects glucose. Open-D tells you what to do about it β€” with your insulin, your timing, and your workout from tomorrow morning already factored in.

SNAQ: RCT-Validated Food AI, No Dosing

SNAQ has something almost no competitor has: a published randomized controlled trial showing a 6.6% improvement in time-in-range from their AI carb counting. That's real clinical validation. They integrate with Dexcom and Libre at $88/year.

But SNAQ is a food tool. It doesn't calculate dosing. No workout features. No coaching. SNAQ tells you what you ate. The other half β€” what to do with that information, when to inject, how your training this morning is affecting your current baseline β€” SNAQ can't touch.

Jade Diabetes: The Original Predictor

Jade Diabetes was ahead of its time. They were among the first to predict glucose hours ahead, dosing off protein, fat, and fiber β€” not just carbs. 43,500 users. Their ML improves over time. Family sharing. Global leaderboards.

The problem is the experience hasn't kept up. Dated UI. No modern AI coaching. No athlete features. No autonomous actions. Jade predicts. Open-D predicts AND coaches AND acts β€” with a UX that doesn't feel like 2016.

What Happens to Your Data

Here's a question most app reviews skip: when a diabetes app is free, how does it make money?

Gluroo is VC-backed and currently in growth mode β€” 43,000 users and counting. Free is the strategy. The business model comes later: B2B clinician dashboards, insurance and payer partnerships, and aggregated anonymized data insights sold to pharmaceutical companies. Your glucose readings, meal logs, and dosing patterns become a dataset. You are not the customer. You are the product.

January AI's enterprise offering explicitly includes data APIs for health systems and research institutions. SNAQ has published multiple RCTs using user data. Even the legacy apps owned by large pharma companies β€” MySugr is Roche, Dexcom has its own data partnerships β€” are sitting on enormous datasets of your most intimate health information.

None of this is necessarily illegal. But you should know it's happening.

Open-D is different in one specific, architectural way: your data never leaves your device. It stays on your phone and nowhere else. There are no servers that hold your glucose readings, meal logs, or dosing history. We have no cloud account to breach. We cannot sell data we cannot see. If you stop using Open-D tomorrow, your data stays on your phone β€” it doesn't live in someone else's infrastructure.

This is a deliberate choice, not a limitation. I have T1D. I know what it feels like to hand your most sensitive health data to a company whose incentives may diverge from yours.

What's Missing From All of Them

Every app I've mentioned treats diabetes management as a data visualization problem. Show the user their glucose, maybe some trends, and hope they figure out the rest. That's not how chronic disease management works.

What I actually need: something that watches continuously, remembers my specific patterns, and warns me before I go out of range β€” with context about why it's happening and what to do. I need an agent, not a dashboard. That's why I built Open-D.

I'm not saying these apps are bad. MySugr is a great logger. Dexcom makes the best CGM hardware. But if you're looking for something that actually learns your diabetes and helps you prevent problems, none of them do that yet.

The Honest Verdict

  • Best logger: MySugr
  • Best free option with broad device support: Gluroo
  • Best food AI without CGM: January AI
  • Best RCT-validated carb counter: SNAQ
  • Best CGM display: Dexcom G7 app
  • Best original predictor: Jade Diabetes
  • Best for T1D athletes, lifters, and people with an active life who need MDI + coaching + action + proactivity: Open-D (yes, I built it β€” because nothing else existed for this use case)

Ready for Your AI Diabetes Agent?

Open-D is the AI Diabetes Agent that watches your glucose 24/7, learns your patterns, and alerts you before problems happen. 40 founding members get free lifetime access.

Get Your AI Diabetes Agent

Libre 3 Β· iOS & Android Β· Free lifetime access

Frequently Asked Questions

What is the best diabetes app in 2026?

The best diabetes app depends on your needs. For logging: MySugr. For free broad device support: Gluroo. For food AI without a CGM: January AI. For RCT-validated carb counting: SNAQ. For T1D athletes who need glucose prediction, insulin-aware coaching, and proactive alerts: Open-D β€” the only app built specifically for active Type 1 diabetics.

How does Open-D compare to Gluroo?

Gluroo is free and covers nearly every CGM and pump, making it a great generalist choice with 43,000 users. Open-D goes deeper for T1D athletes: pharmacokinetic prediction, workout correlation, MDI basal modeling, and AI that can act autonomously (emergency SMS, watch alerts, calendar-aware nudges). Gluroo tracks. Open-D predicts and coaches.

How does Open-D compare to January AI?

January AI predicts glucose from food photos without a CGM β€” impressive for wellness users. But it doesn't track insulin, doesn't support T1D dosing decisions, and has no workout features. Open-D is built for T1D: insulin tracking, pharmacokinetic prediction with active insulin on board, workout correlation, and CGM integration are core, not optional.

Is there a free alternative to Open-D?

Gluroo is free and has broad CGM and pump support, food photo AI, and family sharing β€” a solid free option for general diabetes tracking. Open-D offers free lifetime membership for beta testers. The beta is currently open to a limited number of founding members.

Is my diabetes data safe with free apps?

With free apps, you are the product. Your glucose readings, dosing history, and meal logs are monetized through pharma data deals, insurance partnerships, and B2B clinician platforms. With Open-D, your data never leaves your device β€” not because of a privacy policy, but because there is no server to send it to.

We cannot see it. We cannot sell it. No insurance company can use it to price you differently. No pharma company can enroll you in a study you never agreed to. You are not an experiment. You are a T1D trying to live a normal, active life β€” and your data belongs to you.

🩸

Peter

Founder, Type 1 Diabetic since 1991

I've had Type 1 diabetes since 1991 β€” 35 years of lived experience. I built Open-D because I needed it and nothing else existed. What you read here is based on my real data, my real failures, and my real results. Not medical advice β€” always consult your endocrinologist.